환자 정보 전단
Date revised: 14.08.2015
Print date: 19.08.15
2 / GB- 800315-001-02
Version: 2 / GB
Replaces Version: 1 /
GB
SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO
1907/2006 NEOSEPTAL PLUS
Page 1(12)
SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE
COMPANY/UNDERTAKING
1.1. PRODUCT IDENTIFIER
neoseptal plus
1.2. RELEVANT IDENTIFIED USES OF THE SUBSTANCE OR MIXTURE AND USES
ADVISED AGAINST
USE OF THE SUBSTANCE/PREPARATION
Washing and cleaning products (including solvent based products)
1.3. DETAILS OF THE SUPPLIER OF THE SAFETY DATA SHEET
ADDRESS:
Chemische Fabrik Dr. Weigert GmbH & Co. KG
Mühlenhagen 85
D-20539 Hamburg
Telephone no.
+49 40 789 60 0
Fax no.
+49 40 789 60 120
www.drweigert.com
E-MAIL ADDRESS OF PERSON RESPONSIBLE FOR THIS SDS:
sida@drweigert.de
1.4. EMERGENCY TELEPHONE NUMBER
GBK/ Infotrac: (USA domestic) 1 800 535 5053 or international +1 352
323 3500
SECTION 2: HAZARDS IDENTIFICATION
2.1. CLASSIFICATION OF THE SUBSTANCE OR MIXTURE
CLASSIFICATION (REGULATION (EC) NO. 1272/2008)
Classification (Regulation (EC) No. 1272/2008)
Skin Corr. 1B
H314
Aquatic Acute 1
H400
Acute Tox. 4
H302
Aquatic chronic 2
H411
Eye Dam. 1
H318
CLASSIFICATION IN ACCORDANCE WITH EC DIRECTIVES 1999/45/EC AND
67/548/EEC
Classification
C, R34
N, R50
Xn, R22
2.2. LABEL ELEMENTS
LABELLING ACCORDING TO REGULATION (EC) NO 1272/2008
HAZARD PICTOGRAMS
SIGNAL WORD
Danger
HAZARD STATEMENTS
Date revised: 14.08.2015
Print date: 19.08.15
2 / GB- 800315-001-02
Version: 2 / GB
Replaces Version: 1 /
GB
SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO
1907/2006 NEOSEPTAL PLUS
Page 2(12)
H302
Harmful if swallowed.
H314
Causes severe skin burns and eye damage.
H400
Very toxic to aquatic life.
H411
Toxic to aquatic life with long lasting effects.
PRECAUTIONARY STATEMENTS
P273
Avoid release to the environment.
P280
Wear protective gloves/protective clothing/eye protection/face
protection.
P303+P361+P353
IF ON SKIN (or hair): Take off immediately all contaminated clothing.
Rinse skin
with water/shower.
P305+P351+P338
IF IN EY
전체 문서 읽기
환자 정보 전단 